Thyroscope and TORC Join Forces to Innovate in AI-Driven Precision Medicine for Thyroid Eye Disease

Collaboration Overview



Thyroscope Inc. and The Orbital Radiology Center (TORC) have recently announced a groundbreaking memorandum of understanding aimed at enhancing the monitoring and treatment of Thyroid Eye Disease (TED) through artificial intelligence and advanced imaging techniques. This partnership seeks to utilize smartphone technology, quantitative imaging, and clinical data to create a comprehensive research database for TED.

A New Era in Monitoring TED



Thyroid Eye Disease is an autoimmune condition characterized by various symptoms, including inflammation and vision complications. Traditionally, patients have relied on scheduled clinic visits for assessments, which can be inconsistent and subjective. To address these challenges, Thyroscope will contribute its smartphone-based Glandy platform. This innovative tool enables patients to monitor their condition between clinical appointments by providing assessments based on captured smartphone images and self-reported data. Meanwhile, TORC will leverage its expertise in quantitative orbital imaging to analyze orbital CT and MRI scans, complementing the capabilities of Thyroscope’s technology.

Enhancing Clinical Insights



The collaboration aims to establish a multimodal, longitudinal TED research database that integrates smartphone-based assessments, imaging data, and standardized clinical findings. This database will create opportunities for comprehensive studies on disease activity, treatment responses, and recurrence rates, enabling researchers to better understand TED and potentially offer more personalized patient care. Dr. Shoaib Ugradar, CEO of TORC, emphasizes the necessity of objective measurements and continuous monitoring in moving toward more targeted therapies in TED.

Initial Studies and Future Directions



The partners plan to commence a feasibility study in early 2027 involving about 40 patients receiving TED treatment at BioSight Innovations centers in Los Angeles. Participants will be followed for up to 12 months, allowing for extensive evaluation of smartphone-derived assessments against traditional clinical measurements. The findings from this initial study are expected to help refine the research methodology and validate the use of smartphone assessments in clinical settings.

The Importance of Better Monitoring



Improved monitoring of TED not only allows for timely interventions but also aids clinicians in recognizing variations in disease severity more readily. The integration of home-based measurements aims to enhance the accuracy and timeliness of disease monitoring. As Jaemy Park, CEO of Thyroscope, notes, the collaboration represents an opportunity for continuous assessment rather than relying on infrequent clinical visits.

Future Prospects



As the study progresses, future research phases may introduce larger patient cohorts and additional features, including molecular profiling and tissue-derived insights. By building upon the initial database, the collaboration aspires to contribute significantly to the field of precision medicine, ultimately assisting pharmaceutical companies in developing robust clinical trial endpoints and strategies for patient stratification.

About the Partner Organizations



  • - Thyroscope: A South Korean tech company specializing in AI-driven monitoring tools for thyroid disorders, focusing on improving patient engagement and assessment accuracy.
  • - TORC: A leader in quantitative orbital imaging and research focused on TED, providing imaging services and data analysis for clinical development programs.
  • - BioSight Innovations: A provider of specialized TED treatment and clinical evaluations, supporting ongoing research efforts with a commitment to high-quality patient care.

In conclusion, the collaboration between Thyroscope and TORC represents a significant advancement in the realm of thyroid eye disease, paving the way for enhanced monitoring and a deeper understanding of this challenging condition.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.